FAK inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for FAK inhibitor, covering 2024-08-12 to 2024-08-12. Get the full timeline:
Most recent: Clinical Trial Update: ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK [Phase 1, Phase 2]